As previously published, MACC1 (32) and ADPRH (33) ABCG2 (34), and ANG (35) correlate with glioma cell proliferation, invasion, immune infiltration, drug efficacy, and worse prognosis in glioma patients. This evidence concerns the gene ANG and central nervous system cancer.